Intravenous thrombolysis for acute ischemic stroke during two COVID-19 outbreaks in China: Wuhan pandemic and Beijing pandemic
Abstract Introduction The COVID-19 pandemic has had an impact on the emergency department (ED). Door-to-needle time (DNT) could be prolonged for intravenous thrombolysis (IVT) treatment. We aimed to investigate the impact of two COVID-19 pandemics on the workflow of IVT in our neurovascular ED. Meth...
Main Authors: | Guangshuo Li, Shang Wang, Chuanying Wang, Yahui Hao, Yunyun Xiong, Zeyu Ding, Xingquan Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12883-023-03211-9 |
Similar Items
-
Clinical Significance of Stress Hyperglycemic Ratio and Glycemic Gap in Ischemic Stroke Patients Treated with Intravenous Thrombolysis
by: Li G, et al.
Published: (2022-12-01) -
Intravenous Thrombolysis for Embolic Stroke due to Cardiac Myxoma
by: Mu-Chien Sun, et al.
Published: (2011-01-01) -
Predictive role of pre-thrombolytic hs-CRP on the safety and efficacy of intravenous thrombolysis in acute ischemic stroke
by: Xu-Dong Cheng, et al.
Published: (2023-06-01) -
EXPERIENCE IN USING INTRAVENOUS THROMBOLYSIS IN ISCHEMIC STROKE
by: T. V. Demin, et al.
Published: (2010-03-01) -
Thrombolysis for cerebral ischemia
by: Jennifer E. Fugate, et al.
Published: (2010-10-01)